sb 203580 has been researched along with Hypesthesia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, YX; Li, YY; Liu, XG; Liu, YL; Wei, XH; Wu, CY; Xin, WJ; Xu, JT; Zang, Y; Zhang, T | 1 |
1 other study(ies) available for sb 203580 and Hypesthesia
Article | Year |
---|---|
p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury.
Topics: Animals; Denervation; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Hyperalgesia; Hypesthesia; Imidazoles; Immunohistochemistry; Lumbosacral Region; Male; Microglia; Motor Neurons; Nerve Fibers; Neuralgia; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerve Roots; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha | 2007 |